HCA Healthcare 5% Holder Frisco Holding II Amends 13D After a 2.46% Slide
Frisco Holding II amended its Schedule 13D on HCA at 6:01 p.m. ET Friday, after shares had fallen 2.46% in the regular session. A seven-part notes deal was the other news.

Frisco Holding II filed an amended Schedule 13D on HCA Healthcare, Inc. (NYSE: HCA) at 6:01 p.m. ET on Friday, Nov. 6, in after-hours trading (the session after the 4 p.m. close). The filing updates the disclosure required of holders of 5% or more of a company's shares.
A holder filing with no visible terms, after a drop that came first
HCA shares were already down 2.46% from Thursday's close when the amendment appeared, so the filing cannot explain Friday's regular-session decline. Without its terms, the effect on the stock cannot be judged. Any read is provisional because the next regular session, Monday, has not traded.
Shares slid through Friday and kept falling after hours
HCA closed Thursday at $507.48. In pre-market trading (the session before the 9:30 a.m. ET open), the stock traded at $500.00, down 1.47% from Thursday's close, on only 3,782 shares.
The regular session ended at $494.99, down 2.46% from Thursday's close, on 1,010,552 shares. Relative volume was 0.66 against a 10-day average of 1,782,516 shares a day, so the decline came on lighter-than-usual trading.
In after-hours trading, the last trade was $488.00 at 7:57 p.m. ET, down 1.41% from the 4 p.m. close and 3.84% from Thursday's close, on 147,251 shares. It is not clear how much of that move came after the 13D/A at 6:01 p.m.
Before Friday, the stock had gained 14.04% over the sessions from Oct. 8 to Nov. 5. It jumped 10.34% on Nov. 4 to $510.70 and hit a period high of $521.48 on Nov. 5.
A $6.5 billion notes deal was the other news
HCA announced a proposed senior notes offering on Nov. 2. At 4:19 p.m. ET on Thursday, Nov. 5, after the close, it filed an 8-K with an underwriting agreement dated Nov. 2. The issuer is HCA Inc., the operating subsidiary, and HCA Healthcare guarantees the notes as parent. The agreement covers seven tranches of senior (unsecured) notes:
- $500 million of 5.20% notes due 2028
- $300 million of floating-rate notes due 2028
- $1 billion of 5.35% notes due 2029
- $1.25 billion of 5.50% notes due 2031
- $1.2 billion of 5.75% notes due 2033
- $1.5 billion of 6.00% notes due 2036
- $750 million of 6.50% notes due 2056
Mizuho, Barclays, BofA Securities and Wells Fargo are the underwriters' representatives. Use of proceeds was not part of the filing excerpt we reviewed. Shares rose 1.15% in after-hours trading on Thursday, to $513.30, then fell on Friday.
The holder's size against the stock is unknown
HCA's market value is about $103.4 billion and its float (shares available to trade) is about 136.3 million. Friday's regular-session volume was 0.7% of that float.
No ownership percentage for Frisco Holding II and no share count for the amendment were available, so the holder's stake cannot be set against the float or daily volume.
What to watch next
- The text of the 13D/A: whether it reports a change in share count, a sale or a plan.
- Monday's session, the first full regular session after both the 13D/A and the notes filing.
Bottom line
The 13D/A is the new item, and the stock was already lower before it appeared. The notes agreement is the better-documented event of the period. The market's reaction to the amendment is still to come.
This article was processed by WSN Finance AI Analysis and prepared by WSN Editors based on financial analysis.
This article is for informational purposes only and is not investment advice.




